February 2, 2023
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
MOUNTAIN VIEW, Calif. , Feb. 02, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will participate in a fireside chat at
Additional Formats